Northwestern Feinberg School of Medicine is a clinical research site located in Chicago, Illinois, United States 60611.
Crixeo Health Trust Score: 63/100 (FAIR). This profile has not yet been claimed by the site owner.
Northwestern Feinberg School of Medicine has participated in 4 clinical trials.
Therapeutic areas: Geographic Atrophy Secondary to Age-related Macular Degeneration, Type 2 Diabetes Mellitus, Geographic Atrophy.
Sponsors: Apellis Pharmaceuticals, Inc., Eli Lilly and Company.
Trust Score: 63/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.
Northwestern Feinberg School of Medicine has a Crixeo Trust Score of 63/100 (FAIR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.
Northwestern Feinberg School of Medicine has 4 clinical trials on record. Their work covers Geographic Atrophy Secondary to Age-related Macular Degeneration, Type 2 Diabetes Mellitus, Geographic Atrophy.
Northwestern Feinberg School of Medicine has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.
Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.